The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2407
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells ; volume:18 ; number:1 ; day:21 ; month:2 ; year:2018 ; pages:1-13 ; date:12.2018
BMC cancer ; 18, Heft 1 (21.2.2018), 1-13, 12.2018

Creator
O’Brien, Eleanor M.
Contributor
Selfe, Joanna L.
Martins, Ana Sofia
Walters, Zoë S.
Shipley, Janet M.
SpringerLink (Online service)

DOI
10.1186/s12885-018-4129-8
URN
urn:nbn:de:1111-201804176719
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • O’Brien, Eleanor M.
  • Selfe, Joanna L.
  • Martins, Ana Sofia
  • Walters, Zoë S.
  • Shipley, Janet M.
  • SpringerLink (Online service)

Other Objects (12)

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma

Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma

LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma

Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma

The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma

The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma

MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma

Hochschulschrift

MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma

MYCN, proliferative heterogeneity and treatment response in neuroblastoma

Hochschulschrift

MYCN, proliferative heterogeneity and treatment response in neuroblastoma

Related objects